Exercise experiences among persons with multiple sclerosis living in the southeast of the United States

Disability and Rehabilitation ◽

10.1080/09638288.2020.1757767 ◽

2020 ◽

pp. 1-9

Author(s):

Emma V. Richardson ◽

Elizabeth Barstow ◽

Robert W. Motl

Keyword(s):

United States ◽

Multiple Sclerosis ◽

The United States

Download Full-text

Treatment patterns of relapsing remitting multiple sclerosis (RRMS) in Europe and the United States

10.26226/morressier.59a3edacd462b8028d8958b7 ◽

2017 ◽

Author(s):

Joanna White

Keyword(s):

United States ◽

Multiple Sclerosis ◽

The United States ◽

Treatment Patterns ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking Injectable and Oral Disease Modifying Treatments in the United States

Value in Health ◽

10.1016/j.jval.2014.08.933 ◽

2014 ◽

Vol 17 (7) ◽

pp. A404-A405

Author(s):

S. Narayanan ◽

P. O'Meara ◽

J. White ◽

J. Chan ◽

S. Gabriele

Keyword(s):

United States ◽

Multiple Sclerosis ◽

The United States ◽

Oral Disease ◽

Relapsing Remitting ◽

Disease Modifying ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

PND44 Assessing Variations in Transitions in Employment in Relapsing-Remitting Multiple Sclerosis Patients Treated With Either Laquinimod, Interferon Beta 1-a or Placebo: Expoloratory Evidence From the United States Substudy of Bravo

Value in Health ◽

10.1016/j.jval.2012.03.803 ◽

2012 ◽

Vol 15 (4) ◽

pp. A149

Author(s):

C.A. Carroll ◽

M.A. Oleen-Burkey

Keyword(s):

United States ◽

Multiple Sclerosis ◽

Interferon Beta ◽

The United States ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Multiple Sclerosis Patients ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Cost-Effectiveness of Daclizumab Versus Interferon Beta-1A in the Treatment of Patients with Relapsing-Remitting Multiple Sclerosis in the United States

Value in Health ◽

10.1016/j.jval.2018.04.1400 ◽

2018 ◽

Vol 21 ◽

pp. S206

Author(s):

D Rao ◽

E Heidari ◽

KM Kamal ◽

AA Dashputre

Keyword(s):

United States ◽

Multiple Sclerosis ◽

Cost Effectiveness ◽

Interferon Beta ◽

The United States ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Comparison of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Treated With Disease Modifying Treatments (Dmt) In Europe (Eu) And The United States (Us)

Value in Health ◽

10.1016/j.jval.2015.09.2513 ◽

2015 ◽

Vol 18 (7) ◽

pp. A766

Author(s):

S Narayanan ◽

P O’Meara ◽

J White ◽

J Chan ◽

R Hooper ◽

...

Keyword(s):

United States ◽

Multiple Sclerosis ◽

The United States ◽

Relapsing Remitting ◽

Disease Modifying ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Blood group frequencies in multiple sclerosis populations in the United States

Neurology ◽

10.1212/wnl.30.6.671 ◽

1980 ◽

Vol 30 (6) ◽

pp. 671-671 ◽

Author(s):

H. B. Warner ◽

G. S. Merz ◽

R. I. Carp

Keyword(s):

United States ◽

Multiple Sclerosis ◽

Blood Group ◽

The United States

Download Full-text

Health Care Resource Utilization and Cost Among Natalizumab Initiators with Multiple Sclerosis in the United States

Value in Health ◽

10.1016/j.jval.2013.08.1816 ◽

2013 ◽

Vol 16 (7) ◽

pp. A621

Author(s):

M.M. Bonafede ◽

B.H. Johnson ◽

C. Watson

Keyword(s):

United States ◽

Multiple Sclerosis ◽

Health Care ◽

Resource Utilization ◽

The United States ◽

Health Care Resource ◽

Health Care Resource Utilization

Download Full-text

Multiple sclerosis: Frequency, cost, and economic burden in the United States

Journal of Clinical Neuroscience ◽

10.1016/j.jocn.2017.06.005 ◽

2017 ◽

Vol 45 ◽

pp. 180-186 ◽

Author(s):

Alex Y. Chen ◽

Amy O. Chonghasawat ◽

Kevin L. Leadholm

Keyword(s):

United States ◽

Multiple Sclerosis ◽

Economic Burden ◽

The United States

Download Full-text

Heatlh Care Costs Associated with Patients Diagnosed with Relapsing Remitting Multiple Sclerosis Taking Once Daily Teriflunomide Tablets in the United States

Value in Health ◽

10.1016/j.jval.2015.09.054 ◽

2015 ◽

Vol 18 (7) ◽

pp. A878

Author(s):

N Greene ◽

M Greene

Keyword(s):

United States ◽

Multiple Sclerosis ◽

The United States ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis ◽

Download Full-text

Patterns of Use of Tests to Monitor Disease Activity Among Patients With Relapsing Remitting Multiple Sclerosis in the United States and Europe

Value in Health ◽

10.1016/j.jval.2014.08.929 ◽

2014 ◽

Vol 17 (7) ◽

pp. A404

Author(s):

S. Narayanan ◽

P. O'Meara ◽

J. White ◽

J. Chan ◽

S. Gabriele

Keyword(s):

United States ◽

Multiple Sclerosis ◽

Disease Activity ◽

The United States ◽

Patterns Of Use ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text